MedTrace Logo

Study of Antenatal Thyrotropin-Releasing Hormone in Women in Premature Labor to Prevent Lung Disease in Preterm Infants

NCT00004840 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 996

Last updated 2005-06-24

No results posted yet for this study

Summary

OBJECTIVES:

I. Assess the efficacy and safety of antenatal administration of thyrotropin-releasing hormone to women in premature labor to improve pulmonary outcomes in preterm infants.

Conditions

  • Respiratory Distress Syndrome

Interventions

DRUG

thyrotropin-releasing hormone

Sponsors & Collaborators

Principal Investigators

  • Roberta A. Ballard · Children's Hospital of Philadelphia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE

Eligibility

Min Age
20 Years
Max Age
36 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-05-31
Completion
1998-06-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004840 on ClinicalTrials.gov